Art Torres, California Democratic Party Chair Sends Letter of Resignation

This came to me via email just three minutes ago:

My Fellow Democrats,

It has been an honor to have served for thirteen years as Chairman of the most incredible state Democratic Party in the nation. Together we have made great strides in improving our Party by registering voters with the Bounty program, by grassroots activists opening up offices and creating a sense of community and service to many, and by electing Democrats to the Assembly, Senate and Congress who are protecting the values we all cherish in our state.

Our Party has also embraced our young people and they have joined with us as never before, creating a new generation of Democratic voters and activists. We have elected the first woman Speaker of the House, Nancy Pelosi of California -- one of the highest offices in our country. And of course, California proudly provided a strong margin of victory to elect President Barak Obama.

We are all proud of what President Obama has accomplished during his first 100 days, giving our nation strong initiatives to renew and reinvest in our economy and improve the quality of our lives in the most difficult of times. He is a President who will provide great leadership for our country and our world.

Since 2004, we have added six blue counties with the help of dedicated folks in Alpine, Stanislaus, San Bernardino, San Diego, San Joaquin, and Ventura. We also increased our numbers in Orange County to nearly 34% Democratic registration. These are not small achievements! This is the result of a huge amount of hard work by very dedicated Democrats.

In short, I leave the new Chair and Party leadership a healthy Democratic Party, both politically and financially, as I move to another chapter in my life -- the Vice Chairmanship of the Independent Citizens Oversight Committee of the California Institute for Regenerative Medicine (CIRM), which was created by the voters as Proposition 71 in 2004.

As a colon cancer survivor, I will also be a patient advocate for CIRM in my new role. I join a team of dedicated scientists and policy makers to help raise the more than $400 million needed to fund the research necessary to target diseases that have plagued so many California families. Every day I spend at CIRM headquarters, I sense the excitement of a field of science moving forward rapidly, in fact more rapidly than anyone on the science staff there imagined possible even a couple years ago. When CIRM adopted a scientific strategic plan in October 2006 the scientists there envisioned reaching a stage this year where they could fund “disease teams” that would combine basic researchers and clinicians to work together to develop a therapy ready for clinical trials three-to-four years from now.

In 2006 they predicted funding one or two such teams that would be ready for this challenge today. But when the initial grant applications for the Disease Team Awards were counted a couple weeks ago, there were 73 of them. That is 73 California research teams that think they can get a stem-cell based therapy ready for clinical trials within four years. These teams are targeting a broad array of diseases from osteoarthritis and blindness to cancer and a host of neurodegenerative diseases. Only a subset of these applications will make it through CRIM’s rigorous grant review process, which strives to bet on only the very best science in which to make California’s investment, but no matter the outcome of the grant reviews, this represents a tremendous acceleration toward reaching the promise of stem cells.

The California research community has been able to get to this point in large part because of three years of sustained funding from CIRM. Since the agency issued its first training grants in April of 2006 it has been able to provide consistent support for its new cadre of stem cell researchers. All the scientists I talk to tell me that this type of sustained funding is what science requires to get the results that create new therapies and even cures and, in turn, the jobs that the fast growing biotech industry will provide for Californians. CIRM’s ability to continue this sustained funding is linked to the budgetary health of the state and the state’s ability to issue bonds that support CIRM’s work. So the health and well being of patients in California – and around the world – is one more thing to keep in mind as we vote on the budget initiatives May 19.

This letter is not a goodbye for me, but rather a fulfillment of new path ahead – as we all continue to make a difference in the lives of Californians.

God speed my fellow Democrats!

Sincerely,

Art Torres

Sen. Art Torres (Ret.)
Chairman, California Democratic Party